RESEARCH TRIANGLE PARK, N.C., May 15 /PRNewswire/ -- Dennis Gillings, CBE, Chairman and CEO of Quintiles Transnational Corp., today dedicated a new Quintiles facility in Overland Park, Kan., with Secretary David Kerr of the Kansas Department of Commerce and other dignitaries attending.
The four-story, 236,000-square-foot building is the new home of Quintiles’ regional Clinical Development Services (CDS) and Clinical Pharmacology units previously located in Kansas City, Mo., as well as the Phase I Clinical Research unit that had been in nearby Lenexa, Kan. The new Phase I unit has a 150-bed capacity, triple the space in the Lenexa unit, and the building provides room for up to 200 more employees.
The new facility gives the Overland Park office room it needs to expand its activities in support of regional and global clinical research, Gillings said. “Ultimately, however, this building is about even more than the creation of jobs in Overland Park and the growth of Quintiles,” he said. “It is about improving healthcare -- for people in Kansas, across the United States and around the world.”
Dignitaries attending the event included Thomas Thornton, President and CEO of the Kansas Bioscience Authority, and Carl Gerlach, Mayor of Overland Park.
Stan McDermott, Vice President and General Manager, Clinical Development Services, Quintiles, Overland Park, said: “This expansion is good for Quintiles and benefits the state of Kansas and the Kansas City metropolitan area. It will bring many highly skilled jobs to the region and contribute to the growth of bioscience in the area.”
Quintiles employs about 750 full-time workers in the Kansas City area in CDS, Clinical Pharmacology and Phase I.
About Quintiles
Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, financial partnering and commercialization for the pharmaceutical, biotechnology and healthcare industries. With about 17,000 employees and offices in more than 50 countries, it is focused on providing customers with solutions that are the gold standard of the industry. For more information, please visit the company’s Web site at www.quintiles.com.
Quintiles Transnational Corp.
CONTACT: Media Relations, Dick Jones, media.info@quintiles.com,+1-919-998-2091; or Investor Relations, Greg Connors, invest@quintiles.com,+1-919-998-2000, both of Quintiles Transnational Corp.
Web site: http://www.quintiles.com/
